Metastatic Tumours
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1. (NCT03525392) | Ipsen | 2018-05-03 |
Track Metastatic Tumours automatically
Every clearance here is in the API, with alerts when new ones post.